Epigallocatechin Gallate in the Regulation of Insulin Secretion
dc.contributor.author | Yuskavage, Julia Kathryn | en |
dc.contributor.committeechair | Liu, Dongmin | en |
dc.contributor.committeemember | Gwazdauskas, Francis C. | en |
dc.contributor.committeemember | Barbeau, William E. | en |
dc.contributor.department | Human Nutrition, Foods, and Exercise | en |
dc.date.accessioned | 2014-03-14T20:36:48Z | en |
dc.date.adate | 2008-06-06 | en |
dc.date.available | 2014-03-14T20:36:48Z | en |
dc.date.issued | 2008-04-30 | en |
dc.date.rdate | 2010-12-22 | en |
dc.date.sdate | 2008-05-14 | en |
dc.description.abstract | In both Type 1 diabetes (T1D) and Type 2 diabetes (T2D), inadequate beta-cell mass and beta-cell dysfunction lead to impaired insulin secretion, and ultimately worsen glycemic control. Green tea has drawn wide attention due to its possible health-promoting properties, including enhancement of beta-cell function. We assessed the acute and relative long-term effects of epigallocatechin gallate (EGCG) on insulin secretion and synthesis from clonal beta-cells (INS1E cells), rat islets, and human islets, using 0.1, 1, or 5 µM. We determined if EGCG decreased blood glucose in healthy rats acutely, using 50 or 150 mg/kg body weight (BW), and after 12 days of supplementation in drinking water, using 0.1% and 0.5%. In the in vitro studies, EGCG significantly potentiated glucose-stimulated insulin secretion (GSIS) in rat islets (at 0.1, 1, and 5 µM) and human islets (at 1 µM), and elevated insulin content within INS1E cells (at 0.1, 1, and 5 µm) and human islets (at 1 µM), (P<0.05). Nutritional supplementation of EGCG (0.5% in drinking water) for 12 days in healthy rats significantly increased insulin synthesis, compared to that of controls, from 0.2 ± 0.02 to 1.4 ± 0.2 ng/mg protein, without alteration of insulin secretion in isolated islets (P<0.05). These findings demonstrate that EGCG may play a role in the regulation of pancreatic beta-cell function, thereby contributing to an anti-diabetic effect of this agent. | en |
dc.description.degree | Master of Science | en |
dc.identifier.other | etd-05142008-162857 | en |
dc.identifier.sourceurl | http://scholar.lib.vt.edu/theses/available/etd-05142008-162857/ | en |
dc.identifier.uri | http://hdl.handle.net/10919/32761 | en |
dc.publisher | Virginia Tech | en |
dc.relation.haspart | JuliaYuskavageRevisedETD.pdf | en |
dc.rights | In Copyright | en |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | en |
dc.subject | insulin | en |
dc.subject | catechin | en |
dc.subject | diabetes | en |
dc.subject | green tea | en |
dc.subject | EGCG | en |
dc.subject | islets | en |
dc.subject | pancreatic β-cell | en |
dc.title | Epigallocatechin Gallate in the Regulation of Insulin Secretion | en |
dc.type | Thesis | en |
thesis.degree.discipline | Human Nutrition, Foods, and Exercise | en |
thesis.degree.grantor | Virginia Polytechnic Institute and State University | en |
thesis.degree.level | masters | en |
thesis.degree.name | Master of Science | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- JuliaYuskavageRevisedETD.pdf
- Size:
- 500.85 KB
- Format:
- Adobe Portable Document Format